Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/120613
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Martín-Sánchez, Esperanza |
dc.contributor.author | Mendaza, Saioa |
dc.contributor.author | Ulazia-Garmendia, Ane |
dc.contributor.author | Monreal-Santesteban, Iñaki |
dc.contributor.author | Blanco-Luquin, Idoia |
dc.contributor.author | Córdoba, Alicia |
dc.contributor.author | Vicente-García, Francisco |
dc.contributor.author | Pérez-Janices, Noemí |
dc.contributor.author | Escors, David |
dc.contributor.author | Megías, Diego |
dc.contributor.author | López-Serra, Paula |
dc.contributor.author | Esteller, Manel |
dc.contributor.author | Illarramendi, José Juan |
dc.contributor.author | Guerrero-Setas, David |
dc.date | 2018-03-12T13:03:41Z |
dc.date | 2018-03-12T13:03:41Z |
dc.date | 2017-02-28 |
dc.date | 2018-03-12T13:03:41Z |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | 670727 |
dc.identifier.uri | http://hdl.handle.net/2445/120613 |
dc.format | 13 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.15004 |
dc.relation | Oncotarget, 2017, vol. 8, num. 9, p. 15789-15801 |
dc.relation | https://doi.org/10.18632/oncotarget.15004 |
dc.rights | cc-by (c) Martín-Sánchez, Esperanza et al., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Metilació |
dc.subject | Marcadors bioquímics |
dc.subject | Càncer de mama |
dc.subject | Epigenètica |
dc.subject | Methylation |
dc.subject | Biochemical markers |
dc.subject | Breast cancer |
dc.subject | Epigenetics |
dc.title | CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |